SERA
SERA
NASDAQ · Biotechnology

Sera Prognostics Inc-A

$2.01
-0.02 (-0.99%)
As of Apr 1, 3:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
71.2K
Net Income
-28,055,217
Gross Margin
-102.5%
Profit Margin
-39,417.3%
Rev Growth
-33.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -102.5% -102.5% 31.5% 31.5%
Operating Margin -45,066.7% -40,560.2% -8.6% -10.3%
Profit Margin -39,417.3% -37,446.4% -11.0% -9.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 71.2K 106.4K 14.53M 15.74M
Gross Profit -72,953 -108,982 4.57M 4.95M
Operating Income -32,085,215 -43,138,173 -1,252,159 -1,624,991
Net Income -28,055,217 -37,719,891 -1,603,701 -1,555,725
Gross Margin -102.5% -102.5% 31.5% 31.5%
Operating Margin -45,066.7% -40,560.2% -8.6% -10.3%
Profit Margin -39,417.3% -37,446.4% -11.0% -9.9%
Rev Growth -33.1% -33.1% +22.5% +19.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 26.23M 27.41M
Total Equity 39.07M 37.99M
D/E Ratio 0.67 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -31,250,639 -44,350,324 -1,702,906 -1,797,734
Free Cash Flow -884,905 -1,153,129